Website closure: From October 2019 the PCDT Academy website will no longer be live and the learning modules will not be accessible.


Depression on the frontline: The key role of the primary care physician in driving improved disease recognition and ensuring treatment success

Module 1

Depression on the frontline: The key role of the primary care physician in driving improved disease recognition and ensuring treatment success

This module is CME accredited

You will gain an understanding of the true clinical significance of depression, and the screening tools used to confirm a diagnosis. Additionally, you will learn about the challenges of diagnosing depression and the inter-relationship between depression and physical illnesses, including the effect of depression on disease prevalence, mortality rate and treatment costs.

You will discover how to individualise a treatment approach, and how patients can guide decisions. We will discuss the general treatment goals and strategies for depression and you will learn how to identify the main indicators that determine whether or not a patient has responded to treatment.

Depression in the clinic: What guides our choice in initiating treatment?

Module 2

Depression in the clinic: What guides our choice in initiating treatment?

This module is CME accredited

You will learn the about the factors that should guide your initial treatment decisions, the dfferent treatment options available, and factors that can complicate these options.

You will gain an understanding of the dfferent classes of pharmacological therapy available and the pros and cons associated with each. You will identify which factors to consider when prescribing antidepressants.

You will also learn about the principles of different psychological therapies including: guided self-help, cognitive behaviour therapy and interpersonal therapy, and how patients with depression can benefit from these.

Finally, you will discover what the next steps are following initial treatment. We will explain the difference between remission and recovery, and between relapse and recurrence. You will learn to describe the challenges faced in different treatment phases and the reasons why initial treatment may need to be be switched or augmented.

Long-term support for patients with depression

Module 3

Long-term support for patients with depression

This module is CME accredited

You will learn how to optimise therapy by managing residual symptoms and treatment non-adherence. We will describe the common residual symptoms of depression, the impact of these symptoms and how to manage them.

You will gain an understanding of the common reasons why patients may not adhere to their treatment, and how to overcome such reasons and improve adherence in your patients. You will also learn how to switch between antidepressants, and when and why this may be appropriate.

You will determine how to manage depression in patients with physical health conditions and how best to use antidepressants in patients with comorbid medical conditions, including cardiac conditions.

Finally, we will discuss the aims of long-term support for patients, focusing on the types of self-help support available, and support aimed at preventing relapse. We will also address how to recognise when it is right to stop therapy, and how to do this safely.

Long-term support for patients with depression

Cipriani et al. meta-analysis module

Which antidepressant? Can this recent meta-analysis by Cipriani et al. help your clinical-decision making?

This module is not CME accredited

You will learn about a 2018 systematic review and meta-analysis published by Cipriani et al., which compared the efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder.

You will gain an understanding of the key methodology that Cipriani et al. used, including the methods for systematically reviewing the literature, the inclusion and exclusion criteria for studies, and the outcome measures of the meta-analysis.

Finally, you will be able to describe the key results of the meta-analysis; namely the relative efficacy and acceptability of different antidepressants in relation to each other, and in relation to placebos. You will also learn the characteristics of the studies and patients that were included.

After completing the module, you will understand the findings of the most comprehensive evidence currently available and be able to use it – together with evidence-based guidelines – to guide your initial choice of drugs for acute depression in adults.


Price: Free